(ARWR) |
| 0 (0%) 10-18 03:03 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 83.55 |
| Resistance 1: | 72.96 |
| Pivot price: | 61.78 |
| Support 1: | 55.83 |
| Support 2: | 46.45 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -2.280 |
| Book Value | 3.300 |
| PEG Ratio | 0.00 |
| Gross Profit | 4.740 |
| Profit Margin (%) | -47.79 |
| Operating Margin (%) | -226.03 |
| Return on Assets (ttm) | -8.1 |
| Return on Equity (ttm) | -55.2 |
Company news
Sat, 17 Oct 2026
ARWR Nov 2026 65.000 call (ARWR261120C00065000) Stock Historical Prices & Data - Yahoo Finance - Yahoo! Finance Canada
Sat, 17 Oct 2026
ARWR Stock: Goldman Sachs Resumes Coverage With $74 Target As Clinical Catalysts Near - Stocktwits
Fri, 16 Oct 2026
Piper Sandler Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $126 - Moomoo
Fri, 16 Oct 2026
Arrowhead Pharmaceuticals (ARWR) Reports Fresh ARO MAPT Data, Is The Stock Still Cheap? - Yahoo Finance
Thu, 15 Oct 2026
ARWR: Interim ARO-MAPT Data Shows Potential for TRiM™ Platform in CNS Diseases - Yahoo Finance
Thu, 15 Oct 2026
Arrowhead Pharmaceuticals: ARO-MAPT Results Unlock A New Platform (NASDAQ:ARWR) - Seeking Alpha
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
